These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16698734)

  • 1. Antihypertensive medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):20-7. PubMed ID: 16698734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and anticoagulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):11-9. PubMed ID: 16698733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurostimulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):28-36. PubMed ID: 16698735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):37-49. PubMed ID: 16698736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension.
    Gee ME; Campbell NR; Gwadry-Sridhar F; Nolan RP; Kaczorowski J; Bienek A; Robitaille C; Joffres M; Dai S; Walker RL;
    Can J Cardiol; 2012 May; 28(3):383-9. PubMed ID: 22522073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis for and treatment of deep venous thrombosis after stroke: the Post-Stroke Rehabilitation Outcomes Project (PSROP).
    Zorowitz RD; Smout RJ; Gassaway JA; Horn SD
    Top Stroke Rehabil; 2005; 12(4):1-10. PubMed ID: 16698732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.
    Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH
    JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension treatment and outcomes in US nursing homes: results from the US National Nursing Home Survey.
    Simonson W; Han LF; Davidson HE
    J Am Med Dir Assoc; 2011 Jan; 12(1):44-9. PubMed ID: 21194659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of four primary classes of antihypertensive monotherapy in Thai patients.
    Sukonthasarn A
    J Med Assoc Thai; 2000 Oct; 83(10):1202-10. PubMed ID: 11143486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.
    Padma V; Fisher M; Moonis M
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):867-76. PubMed ID: 15500432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
    Koton S; Tanne D; Grossman E
    J Hypertens; 2017 Apr; 35(4):870-876. PubMed ID: 28030430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.